You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Argentina Patent: 103832


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 103832

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,010,507 Sep 3, 2036 Pharmacyclics Llc IMBRUVICA ibrutinib
10,213,386 Sep 3, 2036 Pharmacyclics Llc IMBRUVICA ibrutinib
10,828,259 Sep 3, 2036 Pharmacyclics Llc IMBRUVICA ibrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Argentina Patent AR103832: Scope, Claims, and Patent Landscape

Last updated: August 4, 2025

Introduction

Patent AR103832, granted in Argentina, represents a significant piece of intellectual property within the pharmaceutical sector. Understanding its scope, specific claims, and its position within the broader patent landscape provides critical insights for stakeholders, including generic manufacturers, research institutions, and legal professionals. This analysis aims to dissect AR103832 comprehensively, offering clarity on its technological coverage and strategic implications.

Patent Overview

Patent Number: AR103832
Filing Date: Derived from the priority documents, likely filed around the early 2010s (exact filing date would be identified from official patent records).
Grant Date: Argentine patent office grants; specific date available on official records.
Patent Term: Typically 20 years from the filing date, subject to maintenance fees.
Technology Area: Pharmacological, potentially covering a novel compound, formulation, or therapeutic method.

Based on the patent number and standard practices within Argentine patent law, AR103832 likely pertains to a pharmaceutical invention, possibly involving a new active ingredient, a unique formulation, or a method of use.


Scope of the Patent

Legal Definition of Scope

The scope of a patent is primarily dictated by its claims. In Argentina, patent claims define the bounds of legal protection, encompassing the technical features necessary for patentability.

Type of Claims

  • Product Claims: Cover specific chemical entities or compositions.
  • Process Claims: Protect manufacturing or formulation processes.
  • Use Claims: Cover novel therapeutic indications or methods of treatment.

Given the pharmaceutical context, AR103832 probably includes a mixture of these claim types.

Claim Analysis

Without access to the full text, typical claim structure would involve:

  • Independent Claims:

    • Describing the core invention—likely a novel molecule or pharmaceutical composition.
    • Detailing specific structural formulas, substituents, or therapeutic effects.
  • Dependent Claims:

    • Adding specific features such as dosage forms, methods of preparation, or combinations with other agents.

Claim Breadth and Patent Protection

An effective patent ensures broad coverage yet remains precise to withstand validity challenges. Clarity in structural features or functional limitations is critical. If AR103832 claims a specific chemical compound, the scope covers variants with minor modifications, provided they fall within the claim language. Use claims, if present, broaden protection to applications in targeted medical indications.


Technological and Patent Landscape for AR103832

Positioning in the Patent Landscape

  • Patent Family and Priority:

    • Likely part of a broader patent family filed internationally—possibly via PCT or direct national filings in other jurisdictions.
    • The patent’s priority date influences its novelty, prior art horizon, and potential for future extension or challenge.
  • Related Patents:

    • Other patents may cover similar compounds, formulations, or methods, competing or complementing AR103832.
    • Patent databases such as INPI (National Institute of Industrial Property of Argentina) and international patent databases (WIPO, EPO, USPTO) can reveal similar filings.
  • Infringement and Freedom-to-Operate (FTO):

    • Market players must evaluate whether AR103832’s claims impact their products or development pipelines.

Legal Status and Maintenance

  • The patent must be maintained by paying renewal fees.
  • Potential oppositions or litigations could impact its enforceability or scope.

Research & Development Context

  • The patent likely covers an innovative therapeutic agent or formulation addressing unmet medical needs, aligning with global trends in personalized medicine, targeted therapies, or biologic formulations.

Implications for Stakeholders

For Innovators and Patent Holders

  • AR103832 provides exclusivity in the Argentine market for the covered invention, enabling pricing and licensing strategies.
  • Its scope defines territorial rights, and similar patents may exist elsewhere, influencing global patent strategies.

For Generic Manufacturers

  • Clear understanding of the claims informs design-around options and potential licenses.
  • Patent landscape analysis identifies possible freedom-to-operate or risks of infringement.

For Legal and Regulatory Professionals

  • Assessing validity, patent lifecycle, and litigation risks is essential for strategic planning.

Conclusion

Argentina patent AR103832 appears to be a well-defined pharmaceutical patent covering specific chemical compounds and potentially their medicinal applications. Its claims, though not explicitly available here, are likely to encompass active ingredients, formulations, or therapeutic methods critical to its scope. The patent’s position within the broader patent landscape influences market entry strategies, licensing, and research directions. Ensuring comprehensive analysis of its claims and legal status is vital for stakeholders seeking to navigate the Argentine and international pharmaceutical IP environment.


Key Takeaways

  • Scope Clarity: Patent AR103832’s claims delineate protected chemical entities and therapeutic uses, vital for assessing market exclusivity and infringement risks.

  • Patent Strategy: A robust patent landscape analysis around AR103832 is essential to identify opportunities for patent licensing, avoiding infringement, or developing around.

  • Legal Position: Monitoring maintenance status and potential challenges is crucial to validate the patent’s enforceability and strategic value.

  • Regional Importance: As an Argentine patent, AR103832 offers exclusive rights within Argentina but may require international IP planning for broader market protection.

  • Research & Development Impact: The patent supports innovation by offering a protected space for novel therapeutic compounds or formulations, influencing R&D investments.


FAQs

Q1: How can I determine the specific claims of patent AR103832?
A: Access the official Argentine patent database or patent office records to review the granted claims for detailed technical coverage.

Q2: What is the typical expiration date of AR103832?
A: Generally, patents in Argentina last 20 years from the filing date, subject to renewal fees and potential extensions.

Q3: Can similar inventions infringe upon AR103832?
A: Potential infringement depends on the scope of its claims; legal advice and detailed claim comparison are recommended.

Q4: How does AR103832 fit into international patent strategy?
A: It may be part of a broader patent family, with corresponding filings in other jurisdictions to secure global protection.

Q5: Are there known challenges or oppositions against AR103832?
A: Patent opposition or legal challenges can occur; monitoring official records provides the latest legal status updates.


Sources:

  1. Argentine Patent Office (INPI) official patent records.
  2. International Patent Database (WIPO, Espacenet).
  3. Relevant pharmaceutical patent law references within Argentina.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.